These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 18386953

  • 1. Challenges and choices: an audit of the management of nausea, vomiting and bowel obstruction in metastatic ovarian cancer.
    Walker J, Lane P.
    Contemp Nurse; 2007 Dec; 27(1):39-46. PubMed ID: 18386953
    [Abstract] [Full Text] [Related]

  • 2. Implementation of best practice for chemotherapy-induced nausea and vomiting in an acute care setting.
    Chung SK, Ahn MJ, Yoo JY, Choi M, Hyang N, Woo SR, Kim SS, Kim SA, Oh EG.
    Int J Evid Based Healthc; 2011 Mar; 9(1):32-8. PubMed ID: 21332661
    [Abstract] [Full Text] [Related]

  • 3. [Symptomatic alleviation of gastrointestinal symptoms].
    Baekke J, Meisner S, Bentsen HH.
    Ugeskr Laeger; 2007 Oct 29; 169(44):3759-62. PubMed ID: 18028844
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
    Jatoi A, Podratz KC, Gill P, Hartmann LC.
    J Support Oncol; 2004 Oct 29; 2(4):323-34; discussion 334-7. PubMed ID: 15357517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of clinical pictures in the management of nausea and vomiting: a prospective audit.
    Bentley A, Boyd K.
    Palliat Med; 2001 May 29; 15(3):247-53. PubMed ID: 11407196
    [Abstract] [Full Text] [Related]

  • 8. Nonpharmacologic management of chemotherapy-induced nausea and vomiting.
    King CR.
    Oncol Nurs Forum; 1997 Aug 29; 24(7 Suppl):41-8. PubMed ID: 9282380
    [Abstract] [Full Text] [Related]

  • 9. [Nausea is a common symptom in palliative care. Choice of treatment is based on the cause].
    Strang P, Jakobsson M.
    Lakartidningen; 1999 Apr 07; 96(14):1743-5. PubMed ID: 10222693
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Malignant bowel obstruction: a review of current treatment strategies.
    Dolan EA.
    Am J Hosp Palliat Care; 2011 Dec 07; 28(8):576-82. PubMed ID: 21504999
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Palliative and end-of-life care for patients with ovarian cancer.
    Radwany SM, von Gruenigen VE.
    Clin Obstet Gynecol; 2012 Mar 07; 55(1):173-84. PubMed ID: 22343236
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.
    Shima Y, Ohtsu A, Shirao K, Sasaki Y.
    Jpn J Clin Oncol; 2008 May 07; 38(5):354-9. PubMed ID: 18490369
    [Abstract] [Full Text] [Related]

  • 19. Bowel obstruction and delirium: managing difficult symptoms at the end of life.
    Lynch M, Dahlin C, Bakitas M.
    Clin J Oncol Nurs; 2012 Aug 07; 16(4):391-8. PubMed ID: 22842690
    [Abstract] [Full Text] [Related]

  • 20. Management of intestinal obstruction in ovarian cancer.
    Krebs HB, Helmkamp F.
    Oncology (Williston Park); 1989 May 07; 3(5):25-31; discussion 31-2, 35-6. PubMed ID: 2577883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.